Skip to main content
. 2019 Sep 26;14:2205–2217. doi: 10.2147/COPD.S213947

Table 3.

Spirometry Values, Sputum Culture, Eosinophil Count, Radiology And Echocardiogram Results In All Patients (Available Data)

Investigations Parameters Results
Spirometry results FEV1 (L) 1.26±0.59 (n=175)
FEV1 (%) 42.30±18.24 (n=175)
FVC (L) 2.13±0.72 (n=175)
FVC (%) 56.35±17.22 (n=175)
FEV1/FVC<0.7 138/175 (78.86%)
FEV1/FVC ratio (mean) 0.56±0.17 (n=175)
Post-bronchodilator values
FEV1/FVC (mean) 0.57±0.17 (n=156)
TLC (%) 77.54±26.10 (n=39)
DLCO (%) 59.33±35.00 (n=38)
Bronchodilator response No 102/143 (71.33%)
Yes 41/143 (28.67%)
Chest X-ray findings COPD and hyperinflated 72/227 (31.58%)
Normal 58/227 (25.44%)
COPD and bronchiectasis 49/227 (21.49%)
Predominant bronchiectasis 26/227 (11.40%)
COPD and cardiomegaly 9/227 (3.95%)
COPD and pulmonary infiltrates 5/227 (2.19%)
Nodules 4/227 (1.75%)
COPD and interstitial opacity 4/227 (1.75%)
Chest CT scan findings Bronchiectasis and emphysema 53/139 (38.12%)
Predominant emphysema 41/139 (29.50%)
Emphysema and fibrosis 18/139 (12.95%)
Lung nodules 17/139 (12.23%)
Normal 10/139 (7.19%)
Cardiac echocardiogram findings Normal 35/93 (37.63%)
Valvular anomalies 26/93 (27.96%)
Pulmonary hypertension 13/93 (13.98%)
Left ventricle systolic dysfunction 11/93 (11.83%)
Right ventricle dysfunction 8/93 (8.60%)
Blood count Eosinophil count 0.29±0.34 (n=187)
Sputum culture results Oropharyngeal flora 66/160 (41.25%)
Pseudomonas 21/160 (13.13%)
Streptococcus pneumoniae 5/160 (3.13%)
Aspergillus 4/160 (2.50%)
Haemophilus influenzae 7/160 (2.38%)
Staphylococcus aureus 3/160 (1.88%)
NTM 2/160 (1.25%)
Pseudomonas and H. influenzae 2/160 (1.25%)
Pseudomonas and NTM 1/160 (0.63%)
Pseudomonas and Staphylococcus 1/160 (0.63%)
S. pneumoniae and H. influenzae 1/160 (0.63%)
Nil 24/160 (15.00%)
Other 23/160 (14.38%)

Abbreviations: FEV1, forced expiratory volume in one second; FVC, forced vital capacity; TLC, total lung capacity; DLCO, diffusing capacity of the lungs for carbon monoxide; COPD, chronic obstructive pulmonary disease; NTM, non-tuberculous mycobacterium.